These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31822542)

  • 1. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Stroke in a Young Patient with Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Quo Vadis?
    Feil K; Heinrich J; von Falkenhausen AS; Becker R; Küpper C; Müller K; Thunstedt DC; Sinner MF; Kääb S; Kellert L
    Case Rep Neurol; 2020; 12(1):45-49. PubMed ID: 32110227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study.
    Badoz M; Derimay F; Serzian G; Besutti M; Rioufol G; Frey P; Guenancia C; Ecarnot F; Meneveau N; Chopard R
    BMJ Open; 2023 Sep; 13(9):e074584. PubMed ID: 37699623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale.
    Toh KZX; Koh MY; Ho JSY; Ong KHX; Lee YQ; Chen X; Fang JT; Chong EY; Lim ICZY; Teo YH; Teo YN; Chua CYK; Lim Y; Chan BPL; Sharma VK; Yeo LLL; Sia CH; Tan BYQ
    Cerebrovasc Dis; 2023; 52(5):503-510. PubMed ID: 36455524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
    Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
    J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
    Diener HC; Wachter R; Wong A; Thijs V; Schnabel RB; Ntaios G; Kasner S; Rothwell PM; Passman R; Saver JL; Albers BA; Bernstein RA
    Int J Stroke; 2023 Apr; 18(4):400-407. PubMed ID: 36050817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
    Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of echocardiographic and clinical characteristics in embolic stroke and migraine patients with patent foramen ovale.
    Polat F; Kaya Z; Yaylak B; Onuk T
    Echocardiography; 2024 Feb; 41(2):e15770. PubMed ID: 38379240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
    Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
    JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
    Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
    Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patent foramen ovale in embolic stroke of undetermined source patients: Malaysian experts' consensus.
    Albart SA; Yusof Khan AHK; Wan Zaidi WA; Muthuppalaniappan AM; Kandavello G; Koh GT; Leong MC; Liew HB; Ong BH; Viswanathan S; Hoo FK; Looi I; Yap YG; Law WC
    Med J Malaysia; 2023 May; 78(3):389-403. PubMed ID: 37271850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
    Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
    Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraventricular Extrasystoles on Standard 12-lead Electrocardiogram Predict New Incident Atrial Fibrillation after Embolic Stroke of Undetermined Source: The AF-ESUS Study.
    Ntaios G; Perlepe K; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Koroboki E; Manios E; Makaritsis K; Michel P; Vemmos K
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104626. PubMed ID: 31954605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score.
    Ntaios G; Perlepe K; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
    Int J Stroke; 2021 Jan; 16(1):29-38. PubMed ID: 32423317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source.
    von Falkenhausen AS; Feil K; Sinner MF; Schönecker S; Müller J; Wischmann J; Eiffener E; Clauss S; Poli S; Poli K; Zuern CS; Ziemann U; Berrouschot J; Kitsiou A; Schäbitz WR; Dieterich M; Massberg S; Kääb S; Kellert L
    Ann Neurol; 2023 Mar; 93(3):479-488. PubMed ID: 36373166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.